DRUG STUDY

Dat Generic Brand Classification Indication Mechanism of Dosage Adverse Nursing

e Name Name Action and Reaction Considerations
Frequency
Ceftriaxo Forgram 3rd generation Indicated in Works by inhibiting 2 grams -Pain Assess patient’s
ne cephalosporin patients with the mucopeptide IVTT OD -Induration previous sensitivity
neurologic synthesis in the ANST -Phlebitis reaction to penicillin
complications bacterial cell wall. -Diarrhea or other
, carditis and The betalactam - cephalosphorins.
arthritis. It is moiety of Thrombocyto
also effective Ceftriaxone binds sis Assess patient for
in Gram to -Leucopenia signs and symptoms
negative Carboxypeptidases -Glossitis of infection before
infections, and Respiratory and during the
Meningitis, transpeptidases in infections treatment
Gonorrhea. It the bacterial
is also for cytoplasmic Obtain C&S before
Bone and membrane. These beginning drug
joint enzymes are therapy to identify
infections, involved in cell wall if correct treatment
Lower synthesis and cell has been initiated.
respiratory division by binding
tract to these enzymes, Report signs such as
infections, Ceftriaxone results petechiae,
middle ear in the formation of ecchymotic areas,
infection, defective cell walls epistaxis or other
PID, and cell death. forms of
Septicemia unexplained
and Urinary bleeding
tract
infections. Monitor
hematologic,
electrolytes, renal
and hepatic
function.

Assess for possible

upper infection:
Itching, fever